| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 5 | +40.00% | +3.85% | -0.46% | +4.31% | +6.32% | — |
| 14d | 5 | +0.00% | +8.73% | +0.80% | +7.94% | +5.79% | — |
| 30d | 5 | +20.00% | +7.08% | +1.17% | +5.91% | +7.95% | — |
| 60d | 5 | +20.00% | +3.84% | -2.12% | +5.96% | +7.63% | — |
| 90d | 5 | +60.00% | -11.96% | -4.47% | -7.49% | -6.61% | — |
| 180d | 5(1 pending) | +100.00% | -37.85% | +2.74% | -40.60% | -40.69% | — |
| 1y | 5(1 pending) | +100.00% | -58.27% | +15.43% | -73.70% | -74.02% | — |
| 2y | 5(5 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| RNAC CARTESIAN THERAPEUTICS, INC. | SALE Chief Medical Officer | 3,573 | $6.82 | $24.4K | 58,820 | Jan 6, 2026 | Jan 8, 2026 ↗ | View → |
| RNAC CARTESIAN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 27,000 | — | — | 62,393 | Jan 2, 2026 | Jan 6, 2026 ↗ | View → |
| RNAC CARTESIAN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 77,000 | — | — | 77,000 | Jan 2, 2026 | Jan 6, 2026 ↗ | View → |
| RNAC CARTESIAN THERAPEUTICS, INC. | SALE Chief Medical Officer | 948 | $16.83 | $16.0K | 35,393 | Jan 6, 2025 | Jan 7, 2025 ↗ | View → |
| RNAC CARTESIAN THERAPEUTICS, INC. | SALE Chief Medical Officer | 932 | $16.72 | $15.6K | 36,341 | Jan 3, 2025 | Jan 7, 2025 ↗ | View → |
| RNAC CARTESIAN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 19,000 | — | — | 37,273 | Jan 2, 2025 | Jan 6, 2025 ↗ | View → |
| RNAC CARTESIAN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 56,000 | — | — | 56,000 | Jan 2, 2025 | Jan 6, 2025 ↗ | View → |
| RNAC CARTESIAN THERAPEUTICS, INC. | SALE Chief Medical Officer | 20,000 | — | — | 30,528 | Nov 15, 2024 | Nov 18, 2024 ↗ | View → |
| RNAC CARTESIAN THERAPEUTICS, INC. | PURCHASE Chief Medical Officer | 20,000 | $3.23 | $64.6K | 38,273 | Nov 15, 2024 | Nov 18, 2024 ↗ | View → |
| RNAC CARTESIAN THERAPEUTICS, INC. | SALE Chief Medical Officer | 20,000 | $17.14 | $342.9K | 18,273 | Nov 15, 2024 | Nov 18, 2024 ↗ | View → |
| RNAC CARTESIAN THERAPEUTICS, INC. | SALE Chief Medical Officer | 35,000 | — | — | 50,528 | Nov 14, 2024 | Nov 18, 2024 ↗ | View → |
| RNAC CARTESIAN THERAPEUTICS, INC. | SALE Chief Medical Officer | 35,000 | $16.13 | $564.6K | 18,273 | Nov 14, 2024 | Nov 18, 2024 ↗ | View → |
| RNAC CARTESIAN THERAPEUTICS, INC. | PURCHASE Chief Medical Officer | 35,000 | $3.23 | $113.0K | 53,273 | Nov 14, 2024 | Nov 18, 2024 ↗ | View → |
| RNAC CARTESIAN THERAPEUTICS, INC. | PURCHASE Chief Medical Officer | 85,528 | — | — | 85,528 | Apr 8, 2024 | Apr 10, 2024 ↗ | View → |
| RNAC CARTESIAN THERAPEUTICS, INC. | SALE Chief Medical Officer | 2,565.872 | — | — | 0 | Apr 8, 2024 | Apr 10, 2024 ↗ | View → |
| RNAC CARTESIAN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 703,000 | — | — | 703,000 | Jan 2, 2024 | Jan 4, 2024 ↗ | View → |
| RNAC CARTESIAN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 548,200 | — | — | 548,200 | Jan 2, 2024 | Jan 4, 2024 ↗ | View → |
| RNAC CARTESIAN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 2,565.872 | — | — | 2,565.872 | Nov 13, 2023 | Nov 15, 2023 ↗ | View → |